Business Context and Reporting Period
Company: Advanced Flower Capital Inc. (AFCG)
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: March 31, 2026
Business Overview: AFCG is an institutional lender focused on senior secured loans to lower middle-market companies. Effective January 1, 2026, the Company elected to be regulated as a Business Development Company (BDC) under the Investment Company Act of 1940, transitioning from its prior status as a Real Estate Investment Trust (REIT). This conversion necessitated a change in accounting standards to ASC 946, requiring portfolio investments to be carried at fair value.
Key Financial Metrics
| Metric | Q1 2026 | Q1 2025 |
|---|---|---|
| Total Assets | $394.9 million | $275.6 million |
| Total Liabilities | $209.1 million | $100.0 million |
| Net Assets | $185.8 million | $175.6 million |
| Net Asset Value (NAV) per Share | $7.90 | $7.46 (Beginning of Q1 2026) |
| Investment Income | $9.8 million | $8.5 million |
| Net Investment Income | $4.8 million | $4.1 million (Net Income) |
| Net Increase in Net Assets from Operations | $11.4 million | $4.1 million |
| Cash and Cash Equivalents | $112.7 million | $38.6 million |
| Total Debt Outstanding | $203.0 million | $98.0 million |
| Asset Coverage Ratio | 191% | 278% |
Material Changes vs. Prior Period
- Accounting Transition: The most significant change is the adoption of ASC 946 investment company accounting effective January 1, 2026. This resulted in all loans being measured at fair value, eliminating the Current Expected Credit Loss (CECL) reserve previously held against loans at carrying value. Consequently, Q1 2026 results are not directly comparable to Q1 2025.
- Portfolio Valuation: The Company recognized a net unrealized gain on investments of $6.6 million (net of taxes) in Q1 2026, compared to a net unrealized loss of $0.7 million in Q1 2025. This shift reflects the fair value measurement of the entire portfolio (15 loans) versus the limited fair value accounting in the prior period.
- Leverage and Liquidity: Total debt increased significantly from $98.0 million to $203.0 million, driven by increased utilization of the Revolving Credit Facility (from $21.0 million to $106.0 million) and the new TCGSL Credit Facility ($20.0 million). Cash balances grew from $38.6 million to $112.7 million.
- Expense Structure: Net expenses increased to $4.9 million in Q1 2026 from $4.3 million in Q1 2025. This includes the introduction of an income-based incentive fee of $1.0 million under the new BDC advisory agreement, offset by the elimination of stock-based compensation ($0.6 million in Q1 2025) due to the accelerated vesting of restricted stock prior to conversion.
Guidance, Outlook, and Risks
- Investment Strategy: While maintaining a focus on the cannabis industry, the Company has expanded its mandate to include senior secured lending to companies ancillary to cannabis and other industries outside the sector.
- Portfolio Quality: As of March 31, 2026, 23.5% of the portfolio (by fair value) was on nonaccrual status, representing three loans. The weighted average portfolio grade was 3.2 (Medium Risk).
- Legal Proceedings: The Company is engaged in significant litigation regarding its credit facility with Justice Cannabis Company, which matured without repayment in May 2026. The Company is pursuing remedies against borrowers and guarantors. Additionally, a forbearance agreement was entered into with High End Holdings LLC following a covenant breach.
- Capital Markets: The Company authorized a $5.0 million share repurchase program in May 2026 at a price of $3.50 or less per share. No repurchases were made during Q1 2026.
- Risks: Key risks include the concentration of the portfolio in the cannabis industry (72% of fair value), federal illegality of cannabis affecting borrower operations, interest rate volatility, and the ability to maintain BDC and Regulated Investment Company (RIC) status.
Investor Verification Checklist
- Nonaccrual Exposure: Verify the status and recovery prospects of the three loans on nonaccrual status, which represent $65.8 million in fair value (23.5% of the portfolio).
- Justice Cannabis Litigation: Monitor the outcome of the foreclosure and legal actions against Justice Cannabis Company and its guarantors, given the maturity of the facility without repayment.
- Debt Covenants: Confirm continued compliance with the Revolving Credit Facility covenants, particularly the liquidity requirement of $5.0 million and the asset coverage ratio, especially given the high utilization of the revolver.
- Valuation Methodology: Review the fair value inputs (Level 3) used for the portfolio, specifically the market yields and recovery rates applied to the cannabis-related loans, as these significantly impact reported NAV.
- Dividend Sustainability: Assess the ability to maintain distributions given the reduced distribution rate ($0.05 per share in Q1 2026 vs. $0.23 in Q1 2025) and the impact of the new incentive fee structure on net investment income.